新生血管性年龄相关性黄斑变性中大面积色素上皮脱离的遗传学
结果显示C3 rs2230199的GG基因型在ARI2组频率显著高于PHRC组和NAT2组,而ARMS2和CFH等位基因分布无显著差异。
要点
- C3 rs2230199 GG基因型在难治性大面积色素上皮脱离患者中频率显著升高。
- ARMS2 rs10490924和CFH rs1061170等位基因分布在该表型与整体新生血管性AMD间无差异。
- 该表型可能具有区别于整体新生血管性AMD的独特遗传背景。
核心结论
- C3 rs2230199的GG基因型与大面积血管化色素上皮脱离且对抗VEGF治疗反应不佳的表型显著相关,其关联强度高于整体AMD系列。
研究设计与样本
- 所有样本检测三个单核苷酸多态性:CFH rs1061170、ARMS2 rs10490924、C3 rs2230199。
- 主要结局指标为新生血管性AMD参与者与对照之间等位基因频率的显著差异。
主要发现
- C3 rs2230199 GG基因型在ARI2组频率为55.9%,显著高于PHRC组的6.0%(P < 0.0001;比值比=24.0 [95%置信区间 10.4-55.0])。
- C3 rs2230199 GG基因型在ARI2组频率显著高于NAT2组的5.1%(P < 0.0001;比值比=16.1 [95%置信区间 5.0-51.9])。
- 携带ARMS2 rs10490924 T等位基因或CFH rs1061170 C等位基因的患者分布在ARI2组与NAT2组、PHRC组间相似。
临床怎么用
- 对于大面积血管化色素上皮脱离且抗VEGF治疗反应不佳的新生血管性AMD患者,可考虑C3 rs2230199基因型检测以辅助识别潜在难治表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We hypothesized that severe forms of neovascular age-related macular degeneration (AMD) such as large pigment epithelial detachments poorly responding to anti-vascular endothelial growth factor therapy might present a distinct genotype compared with overall series of neovascular AMD. METHODS: This is a multicenter genetic association study. Sixty-eight patients presenting pigment epithelial detachments resistant to ranibizumab (issued from ARI2 study, register number NCT02157077 on clinicaltrials.gov) were compared with two series of patients derived from previously published clinical studies, presenting neovascular AMD (NAT2 study n = 300 and PHRC study n = 1,127), and with healthy controls (n = 441). The phenotype of neovascular AMD groups was based on visual acuity measurement, fundus examination, spectral-domain optical coherence tomography, and angiographic data. All samples were genotyped for three single-nucleotide polymorphisms: CFH (rs1061170), ARMS2 (rs10490924), and C3 (rs2230199). Significant difference in allele frequency between participants with neovascular AMD and control was the main outcome measurement. RESULTS: The GG genotype of the C3 rs2230199 was significantly more frequent in the ARI2 group (55.9%) than the PHRC group (6.0%, P < 0.0001; odds ratio = 24.0 [95% confidence interval 10.4-55.0]) and the NAT2 group (5.1%, P < 0.0001; odds ratio = 16.1 [95% confidence interval 5.0-51.9]). The repartition of patients carrying a T allele of the ARMS2 (rs10490924) or patients carrying a C allele of the CFH (rs1061170) was similar in the ARI2 group when compared with the NAT2 and PHRC groups. CONCLUSION: In our series, the genotype GG of C3 rs2230199 was more significantly associated with the phenotype of large vascularized pigment epithelial detachment poorly responding to anti-vascular endothelial growth factor therapy than in global AMD series.
引用
- Mouallem-Beziere A, Blanco-Garavito R, Richard F, et al. GENETICS OF LARGE PIGMENT EPITHELIAL DETACHMENTS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2020. PMID: 30681643. doi:10.1097/IAE.0000000000002454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。